Shenzhen Weiguang Biological Products Balance Sheet Health
Financial Health criteria checks 5/6
Shenzhen Weiguang Biological Products has a total shareholder equity of CN¥2.2B and total debt of CN¥646.2M, which brings its debt-to-equity ratio to 29.7%. Its total assets and total liabilities are CN¥3.2B and CN¥998.4M respectively. Shenzhen Weiguang Biological Products's EBIT is CN¥280.7M making its interest coverage ratio 22.8. It has cash and short-term investments of CN¥425.8M.
Key information
29.7%
Debt to equity ratio
CN¥646.23m
Debt
| Interest coverage ratio | 22.8x |
| Cash | CN¥425.77m |
| Equity | CN¥2.17b |
| Total liabilities | CN¥998.40m |
| Total assets | CN¥3.17b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 002880's short term assets (CN¥1.4B) exceed its short term liabilities (CN¥370.6M).
Long Term Liabilities: 002880's short term assets (CN¥1.4B) exceed its long term liabilities (CN¥627.8M).
Debt to Equity History and Analysis
Debt Level: 002880's net debt to equity ratio (10.1%) is considered satisfactory.
Reducing Debt: 002880's debt to equity ratio has increased from 0% to 29.7% over the past 5 years.
Debt Coverage: 002880's debt is well covered by operating cash flow (43.8%).
Interest Coverage: 002880's interest payments on its debt are well covered by EBIT (22.8x coverage).